Home

MCHENRY T TICHENOR

CIK 1034497 · last filed 2020-05-22

MCHENRY T TICHENOR is a corporate insider who has filed 13 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for NGM, was dated May 22, 2020. Across all open-market trades the lifetime net is +$70.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $222.0K across reported positions. 10 SEC filings were submitted jointly with BELO CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$222.0K

Companies

5

Total Filings

13

Lifetime Open-Market Net

$70.0K

Filer Profile

Reported Address
C/O NGM BIOPHARMACEUTICALS, INC.
333 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Related Filers
BELO CORP — 10 joint filings, latest 2014-01-24
UNIVISION COMMUNICATIONS INC — 8 joint filings, latest 2007-03-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NGM BIOPHARMACEUTICALS INC (NGM) Delisted Director 1,872,314 $1.54 $2.88M $0 3 2020-05-22
BELO CORP (BLC) Delisted Director 0 — — $70.0K 7 2013-12-23
BELO CORP (OMTH) Delisted Director 45,343 — — $0 1 2013-05-09
HF Director 9,842 $22.56 $222.0K $0 1 2008-08-01
UNIVISION COMMUNICATIONS INC (UVN) Delisted Director 0 — — $0 1 2007-03-30

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-05-22 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Grant (A) — $0 EDGAR
2019-05-17 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Grant (A) — $0 EDGAR
2019-04-10 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Conv (C) +1,833,332 $0 EDGAR
2013-12-23 BELO CORP (BLC) Delisted Disp (D) −6,250 -$85.9K EDGAR
2013-05-09 BELO CORP (OMTH) Delisted Mixed +6,250 -$46.8K EDGAR
2012-05-09 BELO CORP (BLC) Delisted Mixed +5,337 -$23.9K EDGAR
2011-09-09 BELO CORP (BLC) Delisted Buy (P) +3,780 $20.0K EDGAR
2011-05-12 BELO CORP (BLC) Delisted Mixed +5,384 -$28.3K EDGAR
2010-05-13 BELO CORP (BLC) Delisted Mixed +10,425 -$54.2K EDGAR
2009-12-08 BELO CORP (BLC) Delisted Buy (P) +10,000 $50.0K EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.